Utilizing NOAC's in non-valvular atrial fibrillation patients undergoing PCI

Overview

This independent medical education (IME) series has been created  for English, German and Spanish speaking cardiologists and is designed to showcase the latest updates emerging from the data in novel oral anticoagulants in non-valvular atrial fibrillation patients undergoing PCI.

It will consider the latest recommendations on bleeding risks and the impact this has on the optimum duration of therapy with NOACs, for those patients with atrial fibrillation. In particular, the WOEST, PIONEER and RE-DUAL-PCI studies will be considered.

Upon completion of this activity, participants will:

  1. Apply knowledge gained on the complex nature of antithrombotic therapies in non-valvular AF patients undergoing PCI in a range of clinical scenarios
  2. Increase knowledge on the complications surrounding triple antithrombotic therapy
  3. Understand the latest clinical evidence regarding the use of NOAC therapy in AF patients undergoing PCI

Target Audience

  • Interventional cardiologists
  • Electrophysiologists
  • General cardiologists

Learning Objectives

The objectives of this IME video series aim to:

  • Describe the complex nature and current recommendations for antithrombotic therapy for non-valvular AF patients undergoing PCI  
  • Define the complications associated with TAT  
  • Summarize the latest data utilizing NOAC therapy in AF patients undergoing PCI

Disclosures

Radcliffe-CME requires contributors to our CME programmes to disclose any relevant financial relationships that have occurred within the past 12 months that could create a conflict of interest. These will be identified in the faculty section if applicable:

R-CME Disclaimer / Terms & Conditions

Information contained in our CME programmes is intended for use by registered healthcare professionals. The material presented here does not necessarily represent the views of Radcliffe-CME or companies that support educational programmes for Radcliffe-CME. The information presented may discuss unpublished uses of agents or products that have not been approved by the Europeans Medicines Agency for use in Europe and/or off-label products.

The information should not be considered medical advice on which you should rely and as licensed healthcare professional, you must always use your professional judgement before using our content and should independently verify any information that you choose to rely on. If you are not a licensed healthcare professional you should always seek advice from a healthcare professional prior to acting on the basis of any content on this Website.

Instructions to Participants

There is no fee for taking part in this online learning activity.

Activities are designed to be completed within the suggested timelines and must be completed by the registered user. Physicians should only claim credits for time spent on the activity. To successfully earn credit, participants must complete the activity in full in the indicated time frame.

To complete the course and claim certification participants must:

1. Read the course outline information supplied and complete pre-test questions if supplied prior to starting the activity. Users must read and study the activity in its entirety before completing the post-test questions.

2. Your results will be automatically saved and if a pass score is achieved (where applicable), you may be eligible to claim credit for the activity and receive a certificate of completion.

Course summary
Available credit: 
  • 0.00 Attendance
Course opens: 
02/01/2018
Course expires: 
01/06/2028
Cost:
£0.00
Rating: 
0

Presenting in English:

Dr Robert Byrne, German Heart Center, Munich, Germany

Prof Georg Nickenig, Medical Clinic and PolyClinic II, Bonn University, Bonn, Germany


Presenting in German: 

Prof Stefan Hohnloser, Johann Wolfgang Goethe University, Frankfurt, Germany

Prof Georg Nickenig, Medical Clinic and PolyClinic II, Bonn University, Bonn, Germany


Presenting in Spanish:

Prof Pepe Zamorano, Head of Cardiology, University Hospital Ramón y Cajal, Madrid, Spain

Dr Jose Lopez-Sendon, Chief, Cardiology Department, Hospital University La Paz, Madrid, Spain


This activity has been supported by an unrestricted independent grant from Boehringher Ingelheim

Available Credit

  • 0.00 Attendance

Accreditation Period

Course opens: 
02/01/2018
Course expires: 
01/06/2028

Price

Cost:
£0.00
Please login or register to take this course.